Drug Failure Deals AstraZeneca Fresh Blow (Reuters) Reuters - AstraZeneca Plc suffered its third\setback in two months on Friday as lung cancer drug Iressa\failed to help patients live longer in a major clinical trial,\sending its shares down as much as 9.2 percent.